RankingsPricing
  1. US-listed companies
  2. STAAR SURGICAL CO
  3. Financials
  4. Cash from investing

STAAR SURGICAL COSTAA

Market cap
$1.3B
P/E ratio
SummaryFinancials
Period EndCash from investing (Million USD)YoY (%)
Dec 27, 2024-59-179.65%
Dec 29, 202374-147.54%
Dec 30, 2022-156+1046.03%
Dec 31, 2021-14+62.36%
Jan 1, 2021-8-17.43%
Jan 3, 2020-10+353.36%
Dec 28, 2018-2+114.63%
Dec 29, 2017-1-67.36%
Dec 30, 2016-3+56.88%
Jan 1, 2016-2-49.61%
Jan 2, 2015-4+17.58%
Jan 3, 2014-3+60.67%
Dec 28, 2012-2+141.39%
Dec 30, 2011-1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)